Maria de la Luz Garcia-Hernandez
Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Cancer Vaccines | 3 | 2007 | 21 |
Why?
|
Vaccines, DNA | 3 | 2007 | 16 |
Why?
|
Prostatic Neoplasms | 3 | 2007 | 120 |
Why?
|
Melanoma, Experimental | 2 | 2002 | 13 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2007 | 91 |
Why?
|
Interleukin-17 | 3 | 2009 | 11 |
Why?
|
Neoplasm Staging | 3 | 2003 | 125 |
Why?
|
Immunotherapy, Adoptive | 1 | 2010 | 10 |
Why?
|
Immunotherapy | 1 | 2009 | 48 |
Why?
|
Antigens, Neoplasm | 2 | 2007 | 56 |
Why?
|
Mice, Inbred C57BL | 7 | 2002 | 318 |
Why?
|
Neoplasm Proteins | 1 | 2008 | 110 |
Why?
|
Membrane Glycoproteins | 1 | 2008 | 154 |
Why?
|
Mice | 9 | 2002 | 623 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2002 | 20 |
Why?
|
Carcinoma, Papillary | 1 | 2003 | 16 |
Why?
|
Telomerase | 1 | 2003 | 15 |
Why?
|
Thyroid Neoplasms | 1 | 2003 | 43 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2002 | 113 |
Why?
|
Interleukin-10 | 1 | 2002 | 38 |
Why?
|
Immune Tolerance | 1 | 2002 | 72 |
Why?
|
Lymphoid Tissue | 1 | 2011 | 34 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 64 |
Why?
|
Bronchi | 1 | 2011 | 45 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2009 | 20 |
Why?
|
Macrophages | 1 | 2002 | 148 |
Why?
|
Mice, Knockout | 4 | 2004 | 265 |
Why?
|
Animals | 10 | 2002 | 1031 |
Why?
|
Entamoeba histolytica | 1 | 2008 | 3 |
Why?
|
RNA, Protozoan | 1 | 2008 | 6 |
Why?
|
DEAD-box RNA Helicases | 1 | 2008 | 12 |
Why?
|
Cell Growth Processes | 2 | 2007 | 24 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 43 |
Why?
|
Autoimmunity | 2 | 2007 | 27 |
Why?
|
Mice, Transgenic | 3 | 2009 | 209 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 121 |
Why?
|
Pulmonary Fibrosis | 1 | 2004 | 48 |
Why?
|
Interleukin-4 | 1 | 2004 | 62 |
Why?
|
Male | 6 | 2002 | 1553 |
Why?
|
Dinoprostone | 1 | 2002 | 55 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2010 | 23 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2009 | 2 |
Why?
|
Ovalbumin | 1 | 2010 | 32 |
Why?
|
Inflammation | 1 | 2004 | 208 |
Why?
|
Mice, Inbred C3H | 1 | 2009 | 86 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 32 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2010 | 52 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 210 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2009 | 21 |
Why?
|
GPI-Linked Proteins | 1 | 2008 | 11 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 27 |
Why?
|
T-Lymphocyte Subsets | 1 | 2009 | 70 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2008 | 17 |
Why?
|
Orthomyxoviridae Infections | 1 | 2009 | 29 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 208 |
Why?
|
Rheumatoid Factor | 1 | 2007 | 9 |
Why?
|
Autoantigens | 1 | 2007 | 29 |
Why?
|
DNA, Complementary | 1 | 2008 | 139 |
Why?
|
DNA, Single-Stranded | 1 | 2007 | 32 |
Why?
|
Autoantibodies | 1 | 2007 | 64 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 99 |
Why?
|
Cell Proliferation | 1 | 2009 | 227 |
Why?
|
Disease Models, Animal | 1 | 2010 | 349 |
Why?
|
Thyroidectomy | 1 | 2003 | 21 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 243 |
Why?
|
Time Factors | 1 | 2009 | 896 |
Why?
|
Neoplasm Invasiveness | 1 | 2003 | 105 |
Why?
|
Autocrine Communication | 1 | 2002 | 24 |
Why?
|
Necrosis | 1 | 2002 | 82 |
Why?
|
Lymphotoxin-alpha | 1 | 2011 | 11 |
Why?
|
Neoplasm Transplantation | 1 | 2002 | 67 |
Why?
|
Chemokine CXCL13 | 1 | 2011 | 4 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 32 |
Why?
|
Mice, Inbred BALB C | 2 | 2002 | 176 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2011 | 38 |
Why?
|
Amino Acid Sequence | 2 | 2008 | 319 |
Why?
|
Pneumonia | 1 | 2011 | 85 |
Why?
|
Cell Division | 1 | 2002 | 273 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 233 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 404 |
Why?
|
Transfection | 1 | 2002 | 237 |
Why?
|
Lasers | 1 | 2008 | 35 |
Why?
|
Genetic Complementation Test | 1 | 2008 | 38 |
Why?
|
Female | 2 | 2003 | 1643 |
Why?
|
S Phase | 1 | 2008 | 29 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2008 | 45 |
Why?
|
Phylogeny | 1 | 2008 | 63 |
Why?
|
Conserved Sequence | 1 | 2008 | 73 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2008 | 156 |
Why?
|
Recombinant Proteins | 1 | 2008 | 290 |
Why?
|
Hydroxyproline | 1 | 2004 | 16 |
Why?
|
Granuloma | 1 | 2004 | 38 |
Why?
|
Hypersensitivity, Delayed | 1 | 2004 | 35 |
Why?
|
Niflumic Acid | 1 | 2002 | 3 |
Why?
|
Saccharomyces cerevisiae | 1 | 2008 | 67 |
Why?
|
Cyclooxygenase 1 | 1 | 2002 | 41 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2002 | 45 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2002 | 47 |
Why?
|
Lung Diseases | 1 | 2004 | 112 |
Why?
|
Interferon-gamma | 1 | 2004 | 133 |
Why?
|
Cyclooxygenase 2 | 1 | 2002 | 77 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 224 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 66 |
Why?
|
RNA, Messenger | 1 | 2008 | 394 |
Why?
|
Disease Progression | 1 | 2002 | 244 |
Why?
|
Isoenzymes | 1 | 2002 | 144 |
Why?
|
Pneumonia, Viral | 1 | 2009 | 17 |
Why?
|
Middle Aged | 1 | 2003 | 1161 |
Why?
|
Gene Expression | 1 | 2002 | 291 |
Why?
|
Cytokines | 1 | 2002 | 207 |
Why?
|
Adult | 1 | 2003 | 1317 |
Why?
|
Membrane Proteins | 1 | 2002 | 233 |
Why?
|
Cells, Cultured | 1 | 2009 | 447 |
Why?
|
Humans | 1 | 2003 | 1856 |
Why?
|
